鏉变簽鑳冭吀钘
Land: Taiwan
Spr氓k: kinesisk
Kilde: 琛涚敓绂忓埄閮ㄩ鍝佽棩鐗╃鐞嗙讲 (Ministry of Health and Welfare, Food And Drug Administration)
Send foresp酶rsel.
Aktiv ingrediens:
MAGNESIUM CARBONATE HEAVY;;CALCIUM CARBONATE;;ALUMINUM MAGNESIUM SILICATE;;SCOPOLIA EXTRACT;;FENNEL (FOENICULUM);;CINNAMON (CINNAMON CORTEX ) (CINNAMON BARK);;AMOMI;;SWERTIA;;CLOVE;;DIASTASE ASPERGILLUS ORYZAE(DIASTASE TAKA);;GLYCYRRHIZA (LIQUORICE)
Tilgjengelig fra:
楂樺師璨挎槗鏈夐檺鍏徃 鍙板寳宸垮欢骞冲寳璺竴娈碉紥锛撹櫉 (07330408)
Legemiddelform:
鏁ｅ姂
Sammensetning:
SCOPOLIA EXTRACT (1208004502) (DIL *3) 30MG; DIASTASE ASPERGILLUS ORYZAE(DIASTASE TAKA) (4400002100) (T) 50MG; ALUMINUM MAGNESIUM SILICATE (5604000500) 400MG; CALCIUM CARBONATE (5604001200) (PPT) 250MG; MAGNESIUM CARBONATE HEAVY (5604002406) 100MG; CINNAMON (CINNAMON CORTEX ) (CINNAMON BARK) (5610000100) 100MG; FENNEL (FOENICULUM) (5610000300) 10MG; CLOVE (7200000300) 10MG; GLYCYRRHIZA (LIQUORICE) (9200004400) 50MG; AMOMI (9200014800) 33.33MG; SWERTIA (9200014900) 1.67MG
Enheter i pakken:
琚嬭
Klasse:
瑁姐鍔
Resept typen:
闋堢敱閱斧铏曟柟浣跨敤
Produsert av:
TOA YAKUHIN CO. LTD. NO.26, SANGO, TOYAMA-CITY JP
Indikasjoner:
娑堝寲涓嶈壇銆佽儍閰搁亷澶氥佽吀鍏х暟甯搁啽閰点佽儍鐥
Produkt oppsummering:
瑷婚姺鏃ユ湡: 2000/10/20; 瑷婚姺鐞嗙敱: 鏈睍寤惰岄炬湡鑰; 鏈夋晥鏃ユ湡: 1998/06/16; 鑻辨枃鍝佸悕: TOA STOMACHIC MEDICINES
Autorisasjon status:
宸茶ɑ閵
Autorisasjon dato:
1985-03-05
